Doctors and Web-based Self-management Support Pilot Study
NCT ID: NCT01220310
Last Updated: 2016-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
57 participants
INTERVENTIONAL
2008-10-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Internet Diabetes Self-Management Workshop
NCT00185601
I Can Do This! Managing My Diabetes
NCT06695533
Improving Diabetes Care With Patient Decision Aids - A Trial in Community-based Primary Care
NCT00668590
Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills
NCT02128854
Accessible and Inclusive Diabetes Telecoaching Self-Management Program
NCT04927377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Health professional participants will attend 60-90 minutes teaching sessions with other health professionals, either in person or via Web-Ex, once per week for a total of 4 weeks. The program director and/or clinic managers overseeing these health professionals will make room for these sessions in their clinic schedule, so that you have no clinical or other responsibilities during those times.
During the first session, the Principal Investigator will first read the informed consent/fact sheet to the health professionals and ask for any questions. A copy of the informed consent/fact sheet will be given to each health professional participant, and they will be asked to provide their contact information on a sign up sheet. At that point, they will complete their first survey questionnaire.
Between these group sessions, at the convenience of the participant, the health professional will log-on to the online workshop to observe the patients' progress in the online course. The health professional will be expected to log on 3 times per week for approximately 10 minutes at a time. The health professional will have 2 'homework' assignments during the entire 4 weeks of learning sessions. These consist of thinking critically about how the self-management techniques they observe patients using online might apply to other patients the health professionals observe, whether online or in their clinics.
The health professionals will also be asked to complete voluntary pre- and post-course surveys. There will be time set aside during the first and last learning sessions for them to complete the surveys.
The final learning session will primarily be devoted to a focus group discussion of the learning sessions. The total time commitment to the observational learning sessions is to attend the 4 learning sessions (60-90 minutes apiece once per week), visit the patient online workshop site 3 times per week (for at least 10 minutes a time), and do the 'homework' assignments (which are expected to take 10-20 minutes apiece to complete).
The health professionals will not actually participate in the online workshop for patients. In fact, if they decide to participate in this project, they are instructed not interact in any way with the patients in the online workshop. The health professionals must agree to observe only, not to post on the discussion boards, and not to answer any messages that they may receive via the online messaging system. The workshops are monitored by Stanford staff, and they will take any action necessary if the health professionals alert them to the need to respond to a patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Online diabetes workshop observation and learning sessions
Online diabetes workshop observation and learning sessions
We will, by self-administered pre- and post-intervention surveys, evaluate the effectiveness of the online diabetes workshop observations and learning sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Online diabetes workshop observation and learning sessions
We will, by self-administered pre- and post-intervention surveys, evaluate the effectiveness of the online diabetes workshop observations and learning sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Santa Clara Valley Medical Center
OTHER
Alameda County Medical Center
OTHER
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kate Lorig
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kate R Lorig
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alameda County Medical Center
Oakland, California, United States
O'Connor Hospital
San Jose, California, United States
Santa Clara Valley Medical Center
San Jose, California, United States
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB Protocol ID: 15108
Identifier Type: -
Identifier Source: secondary_id
SU-09242008-1309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.